RDY (NYSE) - Dr. Reddy’s Laboratories Ltd ADR
Exchange: USA Stocks • Country: India • Currency: USD • Type: Common Stock • ISIN: US2561352038
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Web URL:
Classification
Market Cap in USD | 11,626m |
Sector | Healthcare |
Industry | Drug Manufacturers-Specialty & Generic |
GiC SubIndustry | Pharmaceuticals |
TER | 0.00% |
IPO / Inception | 2001-04-11 |
Ratings
Fundamental | 7.51 |
Dividend | 6.03 |
Performance 5y | 6.10 |
Rel. Performance vs Sector | 1.64 |
Analysts | 4.20 |
Fair Price Total Ret. | 65.33 |
Fair Price DCF | todo |
Technical
Growth TTM | 29.98% |
CAGR 5y | 15.82% |
CAGR / Mean Drawdown 5y | 1.23 |
Sharpe Ratio TTM | 1.27 |
Alpha vs SP500 TTM | 21.65 |
Beta vs SP500 5y weekly | 0.42 |
CAPM | 6.29% |
Average Daily Range 2m | 1.09% |
Reversal Oscillator | 14.01 |
Volatility GJR Garch 1y | 22.46% |
Price / SMA 50 | -2.85% |
Price / SMA 200 | 13.42% |
Current Volume | 255.2k |
Average Volume 20d | 249.5k |
Dividends
Yield TTM | 1.45% |
Yield on Cost 5y | 3.02% |
Dividends CAGR 5y | 5.56% |
Consistency of Dividends all time | 93.8% |